IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity. - Wikidata - awgldk - TriplyDB

IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity.

IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity.

http://www.wikidata.org/entity/Q41815590

about

Roles and relevance of mast cells in infection and vaccination Interleukin-1 Family Cytokines in Liver Diseases New era for mucosal mast cells: their roles in inflammation, allergic immune responses and adjuvant development Functional heterogeneity in the basophil cell lineage New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation Strongyloides stercoralis infection in marmosets: replication of complicated and uncomplicated human disease and parasite biology Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.Hsp12.6 expression is inducible by host immunity in adult worms of the parasitic nematode Nippostrongylus brasiliensis.Foxp3⁺ regulatory T cells delay expulsion of intestinal nematodes by suppression of IL-9-driven mast cell activation in BALB/c but not in C57BL/6 mice Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice Basophils and type 2 immunity.Potential effector and immunoregulatory functions of mast cells in mucosal immunity.Approaches for analyzing the roles of mast cells and their proteases in vivo.Correlation of IL-18 with Tryptase in Atopic Asthma and Induction of Mast Cell Accumulation by IL-18.Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.Human mast cells, bacteria, and intestinal immunity.The role of B-cells in immunity against adult Strongyloides venezuelensis.IgG and IgE collaboratively accelerate expulsion of Strongyloides venezuelensis in a primary infection.Innate immune response mechanisms in the intestinal epithelium: potential roles for mast cells and goblet cells in the expulsion of adult Trichinella spiralis.New paradigms in basophil development, regulation and function.Mast cells in health and disease.Diversity and dialogue in immunity to helminths.Role and relevance of mast cells in fungal infections Immunotherapeutic applications of IL-18.Immunoenhancing therapy with interleukin-18 against bacterial infection in immunocompromised hosts after severe surgical stress.Importance of Both Innate Immunity and Acquired Immunity for Rapid Expulsion of S. venezuelensis.Strongyloides infection in rodents: immune response and immune regulation.IgE and mast cells in host defense against parasites and venoms.Effect of different stages of Schistosoma mansoni infection on the parasite burden and immune response to Strongyloides venezuelensis in co-infected mice.Mucosal mast cells are indispensable for the timely termination of Strongyloides ratti infection.Differences in the Importance of Mast Cells, Basophils, IgE, and IgG versus That of CD4+ T Cells and ILC2 Cells in Primary and Secondary Immunity to Strongyloides venezuelensis.Identification of proteins differentially expressed in human monocytes exposed to Porphyromonas gingivalis and its purified components by high-throughput immunoblotting.Regulatory T cells control type I food allergy to Beta-lactoglobulin in mice.The Immunology of Wild Rodents: Current Status and Future Prospects.Evaluation of the immune response against Strongyloides venezuelensis in antigen-immunized or previously infected mice.Mucosal Mesenchymal Cells: Secondary Barrier and Peripheral Educator for the Gut Immune System.The contribution of mast cells to bacterial and fungal infection immunity.Unique Action of Interleukin-18 on T Cells and Other Immune Cells.Nematode-Infected Mice Acquire Resistance to Subsequent Infection With Unrelated Nematode by Inducing Highly Responsive Group 2 Innate Lymphoid Cells in the Lung

P2860

Q26777264-31FDBDB3-9CCC-4D7C-A9B5-A39FACCD4605 Q26778553-F3F89DFD-4DC9-4DB6-8EFE-48A9988BA702 Q26864415-FBC3A73C-226E-4ECD-8D9B-6670D5A22908 Q26998403-FA2D3FCD-B4DB-44F8-9B2E-556CA5254647 Q27687280-9EB4FBAA-9F92-4C20-94A5-B3382BFFD04B Q30613569-7BD3E31A-CE6A-40EF-B6EC-7D77D482E42F Q34416470-36DBD94D-F1D9-43AC-8EE7-DB4F7F84E8D1 Q34712637-EB420F48-3708-4080-95AC-F6578407780C Q35091229-A784406C-8C3F-4E62-A290-4B35D6CBC1F9 Q35807590-5F74EF11-66EA-4DAF-87E4-755E6E49B18A Q36112050-BE890BB3-2BA7-4428-8E7D-A42F5D2C9328 Q36539857-8782F764-87A5-457C-8652-EB877CB9A00B Q36630944-0178D046-F4FB-411B-A16D-AB0776837064 Q36741934-710552D6-4730-414D-A451-D3C60EC49FA5 Q36744984-7D2AEDD0-A92E-4688-B3E5-06873A736D8F Q36819955-54D378A4-BAA7-4D3A-BE93-E93CE94E8814 Q36893179-1AEDF557-096D-40C0-B6F8-CC92B0B4ACA9 Q36970792-6686B01F-DCEF-4A65-9674-F5B810CE20AA Q37138677-B6E7E88D-6973-4349-89C9-85F3E905E3D1 Q37686073-5882E682-B945-4122-9FA6-A67D2248CFE0 Q37841659-53666B9C-7990-4090-AA8A-349BF8A6D794 Q37879452-4DF75B38-B5E8-4FB1-991A-6EF64FA16C98 Q38019500-C8EF26F3-76A2-4AF4-BD4B-796B73A1066D Q38067452-5BE521BF-6848-4691-BD4F-7CDEB4A866E9 Q38081312-27630F38-EE1A-4538-A3B4-9956827696F0 Q38200089-CBB51FEB-17B6-45E0-86A8-2655642CB42B Q38746154-11567338-2DD4-4D99-A680-A6F6933D3059 Q38844328-F3C8C0EB-5558-4921-8442-577FAEAB6E0E Q38966840-F8A5C7BB-8053-43EC-A5EF-A1059F186B11 Q39391889-8BF8B765-30F3-4107-B1F4-488326BEFD40 Q40306118-8F6C9779-60F1-4041-9804-16DCBD242752 Q43197057-7B61A8A9-F752-49EB-B910-44F5133E312B Q44781828-4FBC7FD6-460A-4804-9EE0-04F46E32F72F Q47428982-906777D3-1448-455D-8DC3-F614276FDF15 Q47988444-7F27A6D8-B4D0-402A-82F5-511BA7763163 Q49198292-4BF32159-E3C5-4677-B34D-9B022E7C1772 Q50068978-6C5FD102-32D3-41F8-A500-2DA532D73445 Q55312741-46415477-12D3-43FA-906D-E8C7F9088865 Q57072674-57ECEB7F-64C3-4D99-B53A-DBCF2729A479

P2860

IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity.

http://www.wikidata.org/entity/Q41815590

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

IL-18 with IL-2 protects again ...... endent type 2 innate immunity.

@en

type

label

IL-18 with IL-2 protects again ...... endent type 2 innate immunity.

@en

prefLabel

IL-18 with IL-2 protects again ...... endent type 2 innate immunity.

@en

P1433

Q41815590-5CF13C99-395A-4BFE-888A-A8D621C49BDA

P1476

Q41815590-4E314C88-23C6-4832-8E98-60ED6A794659

P2093

Q41815590-23E96845-09E4-4635-8F8B-A1395716799B

Q41815590-2BB7B8ED-1B20-4195-BC57-F592C515A83C

Q41815590-42D54FB5-F6F5-496A-8AF8-338C9F845613

Q41815590-6AEB78B1-9C3A-41A4-ADA6-A2CDC16B4E8C

Q41815590-D2606244-DB6D-4013-A47F-8DC98AB22240

Q41815590-D3BCB6B7-81B6-4589-BE3C-88C8352F8EB4

Q41815590-E76A6457-05DC-4DED-BE4D-4249DEF52221

P2860

Q41815590-18C75AA8-4C21-47CE-83B1-F45EC81C9AF0

Q41815590-1EB8FA32-ED51-4320-BE10-86646058068C

Q41815590-34BC8B28-D8BD-4B8B-9324-34E90B9FDE78

Q41815590-374124D6-5DCC-4E21-B944-6F110CB05ABA

Q41815590-383DEE59-8EC5-47C8-842A-C977329E0EE0

Q41815590-39C0FC33-B9D8-4F64-8BD7-9AA945AEE79F

Q41815590-3E9EE8E6-6D22-4A06-AA96-839586B9318B

Q41815590-401490DD-E936-48D4-8E63-5C3F0D1C85C0

Q41815590-4177D80D-DC0B-4645-8D42-52FCAC4084E9

Q41815590-43345A0B-7392-4C9B-BCA5-19167782E343

P304

Q41815590-A92C420C-7E0F-4F7D-9673-03B78D40EDC7

P31

Q41815590-CECF5FA2-E015-470D-8B65-50A373914FAB

P356

Q41815590-8E01C126-235E-44D2-9730-11E780017E35

P407

Q41815590-EEDB8A5D-B1E9-4924-8B3F-AFDC54947B13

P433

Q41815590-ECC814EA-9ABC-4FAD-B2D8-1F0F4722B795

P478

Q41815590-B415E74A-36BF-4919-9AC5-1FF46B969B4E

P577

Q41815590-AB459490-6652-4110-ADC6-B4C498380F46

P5875

Q41815590-9D6ACFBB-52E9-42A1-9F06-AE31199BC335

P698

Q41815590-B724EDF9-B661-4E49-BC30-77CC924E282D

P921

Q41815590-861990C4-81B2-4BA8-86AE-04F7D603460F

P932

Q41815590-931CE9B8-8BF9-4FE2-897D-D4CDDBFE8BD7

P356

P1433

Journal of Experimental Medicine

P1476

IL-18 with IL-2 protects again ...... endent type 2 innate immunity.

@en

P2093

Haruhiko Maruyama

http://www.w3.org/2001/XMLSchema#string

Kenji Nakanishi

http://www.w3.org/2001/XMLSchema#string

Naoki Arizono

http://www.w3.org/2001/XMLSchema#string

Nobuo Ohta

http://www.w3.org/2001/XMLSchema#string

Tatsuya Tegoshi

http://www.w3.org/2001/XMLSchema#string

Tomohiro Yoshimoto

http://www.w3.org/2001/XMLSchema#string

Yuki Sasaki

http://www.w3.org/2001/XMLSchema#string

P2860

Essential role of Stat6 in IL-4 signalling

Cloning of a new cytokine that induces IFN-gamma production by T cells

Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor

IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells.

Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.

Immunity to Listeria infection.

IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions

Interleukin-18 regulates both Th1 and Th2 responses.

Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells.

Regulation of immunity to parasites by T cells and T cell-derived cytokines.

P304

607-616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20042202

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7630644

http://www.w3.org/2001/XMLSchema#string

P698

16129701

http://www.w3.org/2001/XMLSchema#string

P921

P932

2212862

http://www.w3.org/2001/XMLSchema#string